Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Neuraxis, Inc. (NRXS) vs Promis Neurosciences (PMN)

Neuraxis, Inc. and Promis Neurosciences are both Biotechnology companies. Neuraxis, Inc. and Promis Neurosciences are of similar size ($103.8M and $97.3M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against 65.2%. Promis Neurosciences has the higher net margin (0.00% vs −159.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Neuraxis, Inc. leads on 8 and Promis Neurosciences on 7.

Valuation

Metric NRXS PMN Biotechnology median
P/E n/m n/m 7.88
P/S 17.24 46,834.02 11.47
P/B 13.61 2.09 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 15.68 24,347.61 10.73
Earnings yield (10.32%) (112.60%) (28.84%)
Free cash flow yield (6.31%) (40.87%) (23.03%)

Profitability

Metric NRXS PMN Biotechnology median
Gross margin 85.56% 0.00% 65.16%
Operating margin (144.51%) 0.00% 0.00%
Net margin (159.01%) 0.00% 0.00%
Free cash flow margin (106.10%) 0.00% 0.00%
Return on equity (153.96%) (172.30%) (57.72%)
Return on assets (98.96%) (127.57%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXS PMN Biotechnology median
Revenue growth (TTM) 65.22% 450.00% 5.64%
EPS growth (last fiscal year) 22.13% (922.18%) —
Revenue growth, 5-year CAGR 13.08% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXS PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.04 7.85 4.73
Net debt to EBITDA 0.64 0.15 0.96

Dividend

Metric NRXS PMN Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric NRXS PMN Biotechnology median
Market cap 97.32m 103.76m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack